Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients
Clinical trial NCT02069704 · COMPLETED
Trial details
- NCT number
- NCT02069704
- Sponsor
- mAbxience Research S.L.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-29
- Primary completion
- 2015-10-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.